Who Supplies Teicoplanin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Teicoplanin exports, with 60+ registered manufacturers shipping to buyers across 44+ countries — yet a handful of companies dominate the shipments. GUFIC BIOSCIENCES LIMITED holds the largest share at 52.4% (export value: $3.3M). Close behind, JODAS EXPOIM PRIVATE LIMITED (4.3%, $272.1K). CIPLA LIMITED (3.7%, $234.7K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Teicoplanin? Top Manufacturers & Their Buyers
Flow of Teicoplanin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Teicoplanin Supplier Network — Key Market Intelligence
The Teicoplanin export market from India is led by GUFIC BIOSCIENCES LIMITED, which alone commands a 52.4% share, shipping $3.3M worth of product across 87 shipments. The second-largest exporter, JODAS EXPOIM PRIVATE LIMITED, contributes $272.1K (4.3%) to the overall market. Combined, the top two suppliers alone account for 56.7% of all Teicoplanin exports, indicating a relatively concentrated supply base.
Across all 60 tracked manufacturers, the total Teicoplanin export value stands at $6.3M from 310 shipments. The market average shipment value is $20.3K. The single largest buyer relationship in terms of trade value is AUSTELL PHARMACEUTICALS ( PTY) LIMITED, receiving $357.5K worth of product.
The combined buyer network spans 13 named purchasing companies, including AUSTELL PHARMACEUTICALS ( PTY) LIMITED, PEOPLE'S BANK,, HANSE SERVICE INTERNATIONALE, M/S. OOO JODAS EXPOIM.., OOOJODAS EXPOIM and 8 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1GUFIC BIOSCIENCES LIMITED
GUFIC BIOSCIENCES LIMITED is the first-largest Teicoplanin exporter from India, with a market share of 52.4% and a total export value of $3.3M across 87 shipments. Their average shipment value of $37.9K is above the market average of $20.3K, suggesting premium or bulk contract pricing.
GUFIC BIOSCIENCES LIMITED serves 5 named buyers in our database. TO THE ORDER OF is the dominant customer, accounting for 72.7% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF — $2.4M across 63 shipments (72.7% of this supplier's total exports)
• AUSTELL PHARMACEUTICALS ( PTY) LIMITED — $357.5K across 9 shipments (10.9% of this supplier's total exports)
• PEOPLE'S BANK, — $197.5K across 5 shipments (6.0% of this supplier's total exports)
• HANSE SERVICE INTERNATIONALE — $172.6K across 5 shipments (5.2% of this supplier's total exports)
• AUSTELL PHARMACEUTICALS ( PTY) LIMITED — $171.3K across 5 shipments (5.2% of this supplier's total exports)
Key Insight: GUFIC BIOSCIENCES LIMITED's per-shipment value of $37.9K is 87% above the market average of $20.3K, consistent with large-order contracts or value-added formulations.
2JODAS EXPOIM PRIVATE LIMITED
JODAS EXPOIM PRIVATE LIMITED is the second-largest Teicoplanin exporter from India, with a market share of 4.3% and a total export value of $272.1K across 5 shipments. Their average shipment value of $54.4K is above the market average of $20.3K, suggesting premium or bulk contract pricing.
JODAS EXPOIM PRIVATE LIMITED serves 3 named buyers in our database. M/S. OOO JODAS EXPOIM.. is the dominant customer, accounting for 58.9% of this supplier's tracked business. Top customers include:
• M/S. OOO JODAS EXPOIM.. — $160.3K across 3 shipments (58.9% of this supplier's total exports)
• OOOJODAS EXPOIM — $96.7K across 2 shipments (35.5% of this supplier's total exports)
• OOOJODAS EXPOIM — $15.0K across 0 shipments (5.5% of this supplier's total exports)
Key Insight: JODAS EXPOIM PRIVATE LIMITED's per-shipment value of $54.4K is 168% above the market average of $20.3K, consistent with large-order contracts or value-added formulations.
3CIPLA LIMITED
CIPLA LIMITED is the third-largest Teicoplanin exporter from India, with a market share of 3.7% and a total export value of $234.7K across 11 shipments. Their average shipment value of $21.3K is above the market average of $20.3K, suggesting premium or bulk contract pricing.
CIPLA LIMITED serves 2 named buyers in our database. MEDPRO PHARMACEUTICA PTY LTD is the dominant customer, accounting for 89.1% of this supplier's tracked business. Top customers include:
• MEDPRO PHARMACEUTICA PTY LTD — $209.1K across 10 shipments (89.1% of this supplier's total exports)
• MEDPRO PHARMACEUTICA PTY LTD — $25.6K across 1 shipments (10.9% of this supplier's total exports)
Key Insight: CIPLA LIMITED's per-shipment value of $21.3K is 5% above the market average of $20.3K, consistent with large-order contracts or value-added formulations.
4NEON LABORATORIES LIMITED
NEON LABORATORIES LIMITED is the fourth-largest Teicoplanin exporter from India, with a market share of 3.4% and a total export value of $215.1K across 6 shipments. Their average shipment value of $35.8K is above the market average of $20.3K, suggesting premium or bulk contract pricing.
NEON LABORATORIES LIMITED serves 2 named buyers in our database. YADEN INTERNATIONAL (PVT) LTD is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• YADEN INTERNATIONAL (PVT) LTD — $215.1K across 6 shipments (100.0% of this supplier's total exports)
• M S ESSENCE LIFE PHA — $0 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: NEON LABORATORIES LIMITED's per-shipment value of $35.8K is 77% above the market average of $20.3K, consistent with large-order contracts or value-added formulations.
5VENUS REMEDIES LIMITED
VENUS REMEDIES LIMITED is the fifth-largest Teicoplanin exporter from India, with a market share of 2.1% and a total export value of $132.9K across 18 shipments. Their average shipment value of $7.4K is below the market average of $20.3K, reflecting a high-volume, competitive pricing strategy.
VENUS REMEDIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• N S O — $45.8K across 6 shipments (34.5% of this supplier's total exports)
• C D R — $32.4K across 4 shipments (24.4% of this supplier's total exports)
• M P C L — $31.5K across 4 shipments (23.7% of this supplier's total exports)
• MEDICAMENTOS AVANZAD — $14.8K across 2 shipments (11.2% of this supplier's total exports)
• A L L — $8.4K across 1 shipments (6.3% of this supplier's total exports)
Key Insight: VENUS REMEDIES LIMITED operates with high shipment frequency (18 shipments) at a per-shipment value of $7.4K, indicating a broad distribution network with many smaller, regular orders.
6FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED
FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED is the fifth-largest Teicoplanin exporter from India, with a market share of 1.7% and a total export value of $107.3K across 5 shipments. Their average shipment value of $21.5K is above the market average of $20.3K, suggesting premium or bulk contract pricing.
FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED serves 2 named buyers in our database. TO THE ORDER is the dominant customer, accounting for 66.5% of this supplier's tracked business. Top customers include:
• TO THE ORDER — $71.3K across 3 shipments (66.5% of this supplier's total exports)
• TO THE ORDER — $36.0K across 2 shipments (33.5% of this supplier's total exports)
Key Insight: FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED's per-shipment value of $21.5K is 6% above the market average of $20.3K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Teicoplanin Flows
Once Teicoplanin leaves the manufacturing plants of companies like GUFIC BIOSCIENCES LIMITED and JODAS EXPOIM PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $6.3M. Hungary absorbs the largest share at 35.6% ($2.2M), followed by Sri Lanka (18.4%) and South Africa (17.9%).
This geographic spread reflects Teicoplanin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Teicoplanin Go? Top Importing Countries & Their Buyers
Trade flow of Teicoplanin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Hungary
Hungary ranks as the first-largest destination for Teicoplanin imports from India, with a total trade value of $2.2M across 0 shipments — representing a 35.6% share of all Teicoplanin exports. The average shipment value of $2.2M is above the global average of $20.3K, indicating high-value procurement contracts or branded formulations.
Key Insight: Hungary's per-shipment average of $2.2M (10925% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Hungary is a key market for Teicoplanin imports from India.
2Sri Lanka
Sri Lanka ranks as the second-largest destination for Teicoplanin imports from India, with a total trade value of $1.2M across 28 shipments — representing a 18.4% share of all Teicoplanin exports. The average shipment value of $41.4K is above the global average of $20.3K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.
Named Teicoplanin importers in Sri Lanka: SLIM PHARMACEUTICALS (PVT) LTD, is the largest buyer, accounting for 21.2% ($245.7K) of this market's total imports.
• SLIM PHARMACEUTICALS (PVT) LTD, — $245.7K (21.2% of Sri Lanka's total)
• YADEN INTERNATIONAL (PVT) LTD — $215.1K (18.6% of Sri Lanka's total)
• PEOPLE'S BANK, — $197.5K (17.0% of Sri Lanka's total)
Key Insight: Sri Lanka's per-shipment average of $41.4K (104% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sri Lanka is a key market for Teicoplanin imports from India.
3South Africa
South Africa ranks as the third-largest destination for Teicoplanin imports from India, with a total trade value of $1.1M across 15 shipments — representing a 17.9% share of all Teicoplanin exports. The average shipment value of $75.1K is above the global average of $20.3K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Teicoplanin importers in South Africa: AUSTELL PHARMACEUTICALS ( PTY) LTD is the largest buyer, accounting for 31.7% ($357.5K) of this market's total imports.
• AUSTELL PHARMACEUTICALS ( PTY) LTD — $357.5K (31.7% of South Africa's total)
• MEDPRO PHARMACEUTICA PTY LTD — $209.1K (18.6% of South Africa's total)
• AUSTELL PHARMACEUTICALS (PTY) LTD, — $195.1K (17.3% of South Africa's total)
Key Insight: South Africa's per-shipment average of $75.1K (270% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
South Africa is a key market for Teicoplanin imports from India.
4Cuba
Cuba ranks as the fourth-largest destination for Teicoplanin imports from India, with a total trade value of $338.0K across 2 shipments — representing a 5.4% share of all Teicoplanin exports. The average shipment value of $169.0K is above the global average of $20.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Teicoplanin importers in Cuba: MEDICUBA, S.A. is the largest buyer, accounting for 100.0% ($338.0K) of this market's total imports.
• MEDICUBA, S.A. — $338.0K (100.0% of Cuba's total)
Key Insight: Cuba's per-shipment average of $169.0K (733% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Cuba is a key market for Teicoplanin imports from India.
5Germany
Germany ranks as the fifth-largest destination for Teicoplanin imports from India, with a total trade value of $336.9K across 3 shipments — representing a 5.4% share of all Teicoplanin exports. The average shipment value of $112.3K is above the global average of $20.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Teicoplanin importers in Germany: HANSE SERVICE INTERNATIONALE is the largest buyer, accounting for 86.8% ($292.5K) of this market's total imports.
• HANSE SERVICE INTERNATIONALE — $292.5K (86.8% of Germany's total)
Key Insight: Germany's per-shipment average of $112.3K (453% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Germany is a key market for Teicoplanin imports from India.
People Also Ask — Teicoplanin Supplier & Trade Network
Who are the top suppliers of Teicoplanin from India?+
Which companies buy Teicoplanin from Indian manufacturers?+
Where does Teicoplanin exported from India go?+
What is the market share of the top Teicoplanin supplier from India?+
What is the average shipment value for Teicoplanin exports from India?+
Is Teicoplanin manufactured in India and exported globally?+
Which country imports the most Teicoplanin from India?+
Who are the buyers of Teicoplanin in Sri Lanka?+
How concentrated is the Teicoplanin supplier market in India?+
How do I find verified buyers for Teicoplanin in specific countries?+
Teicoplanin Trade Network — Key Takeaways
- 1GUFIC BIOSCIENCES LIMITED is India's dominant Teicoplanin exporter with a 52.4% market share and $3.3M in total exports — making it the single most important sourcing entity in this market.
- 2The top 60 suppliers collectively account for 67.7% of all tracked Teicoplanin exports, with a combined trade value of $6.3M.
- 3Hungary is the largest destination market, absorbing 35.6% of India's Teicoplanin exports ($2.2M). Sri Lanka (18.4%) and South Africa (17.9%) follow.
- 4With 310 total shipments averaging $20.3K each, the Teicoplanin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include AUSTELL PHARMACEUTICALS ( PTY) LIMITED, PEOPLE'S BANK,, M/S. OOO JODAS EXPOIM.., OOOJODAS EXPOIM — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 44 countries
Network value: $6.3M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Teicoplanin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Teicoplanin.
- 2.Flow Mapping: 60 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 310 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 44 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
310 Verified Shipments
60 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists